Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Allergy Therapeutics Plc. (AGYTF)

Allergy Therapeutics Plc. (AGYTF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Allergy Therapeutics Plc. Dominion Way West Sussex Worthing X0 BN14 8SA GBR

www.allergytherapeutics.com P: 44-19-0384-4700

Description:

Allergy Therapeutics Plc is a specialty pharmaceutical company focused on allergy vaccination. The company's product pipeline consists of PollinexTrees(R), Pollinex Grasses + Rye(R), Skin Prick Testing, Diagnostic Products and Service. Allergy Therapeutics Plc is based in Worthing, the United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 13,779
Enterprise Value, $K 29,019
Shares Outstanding, K 688,953
Annual Sales, $ 73,420 K
Annual Net Income, $ -61,470 K
EBIT, $ 0 K
EBITDA, $ -38,430 K
60-Month Beta 519.17
% of Institutional Shareholders 0.00%
Float, K 688,953
% Float 100.00%
Short Volume Ratio 1.00

Growth:

1-Year Return 0.00%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth -20.25%
5-Year Earnings Growth -350.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 01/03/24
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

AGYTF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -83.72%
Debt/Equity -5.75
Price/Sales 0.19
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.01
Interest Coverage -2.55
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar